TSCAN THERAPEUTICS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -30.2% | -30.2% | -25.8% |
| FY2022 | -66.6% | -51.4% | -33.3% |
| FY2023 | -59.1% | -50.2% | -32.8% |
| FY2024 | -52.9% | -46.7% | -34.4% |
| FY2025 | -105.4% | -83.4% | -56.7% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -30.2% | -30.2% | -25.8% |
| FY2022 | -66.6% | -51.4% | -33.3% |
| FY2023 | -59.1% | -50.2% | -32.8% |
| FY2024 | -52.9% | -46.7% | -34.4% |
| FY2025 | -105.4% | -83.4% | -56.7% |